Patient Assistance Program (PAP) Eligibility Requirements:
Patients who meet program eligibility criteria and financial need requirements are eligible to receive a free supply of Sogroya® or Norditropin® for up to one (1) year with requalification process to occur thirty (30) days prior to PAP expiration.
JumpStart™ and Interim Program eligibility
Patients who have been prescribed Sogroya® or Norditropin® for an FDA-approved indication and who have commercial insurance may be eligible to receive a limited supply of free product from JumpStart™ or the Interim Program. Patients who participate in any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to participate in JumpStart™ or the Interim Program.
JumpStart™ and Interim Program product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.
Before taking Norditropin®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works.
Norditropin® may cause serious side effects, including:
The most common side effects of Norditropin® include:
Please click here for Norditropin® Prescribing Information.
Norditropin® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Before taking Norditropin®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works.
Norditropin® may cause serious side effects, including:
The most common side effects of Norditropin® include:
Please click here for Norditropin® Prescribing Information.
Norditropin® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.
The most common side effects of Sogroya® in children include: common cold, headache, fever, pain in extremity, and reaction to injection
The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)
Please click here for Sogroya® Prescribing Information.
Sogroya® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.